{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:28:02Z","timestamp":1754195282453},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,7]]},"DOI":"10.7759\/cureus.68862","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T12:37:52Z","timestamp":1725712672000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparing Selective Serotonin Reuptake Inhibitors (SSRIs) Alone and in Combination With Beta-Blockers for Treating Panic Disorders: A Prospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Doaa","family":"Bajaber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alsubhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saja A","family":"Felimban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruba Z","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawaf  S","family":"Allahyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad Y","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feras B","family":"Kofiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz A","family":"Almatrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saif A","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1429403","article-title":"Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines","volume":"17","author":"Quagliato LA","year":"2018","unstructured":"Quagliato LA, Freire RC, Nardi AE. Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines. Expert Opin Drug Saf. 2018, 17:315-24. 10.1080\/14740338.2018.1429403","journal-title":"Expert Opin Drug Saf"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1779220","article-title":"Relapse prevention in panic disorder with pharmacotherapy: where are we now?","volume":"21","author":"Caldirola D","year":"2020","unstructured":"Caldirola D, Alciati A, Dacc\u00f2 S, Micieli W, Perna G. Relapse prevention in panic disorder with pharmacotherapy: where are we now?. Expert Opin Pharmacother. 2020, 21:1699-711. 10.1080\/14656566.2020.1779220","journal-title":"Expert Opin Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01161-7","article-title":"Age at onset of mental disorders worldwide: large-scale meta-analysis of\u00a0192 epidemiological studies","volume":"27","author":"Solmi M","year":"2022","unstructured":"Solmi M, Radua J, Olivola M, et al.. Age at onset of mental disorders worldwide: large-scale meta-analysis of\u00a0192 epidemiological studies. Mol Psychiatry. 2022, 27:281-95. 10.1038\/s41380-021-01161-7","journal-title":"Mol Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1836","article-title":"Lifetime prevalence and age-of-onset distributions of mental disorders in the Saudi National Mental Health Survey","volume":"29","author":"Altwaijri YA","year":"2020","unstructured":"Altwaijri YA, Al-Subaie AS, Al-Habeeb A, et al.. Lifetime prevalence and age-of-onset distributions of mental disorders in the Saudi National Mental Health Survey. Int J Methods Psychiatr Res. 2020, 29:10.1002\/mpr.1836","journal-title":"Int J Methods Psychiatr Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285940","article-title":"A latent class analysis of the socio-demographic factors and associations with mental and behavioral disorders among Australian children and adolescents","volume":"18","author":"Afroz N","year":"2023","unstructured":"Afroz N, Kabir E, Alam K. A latent class analysis of the socio-demographic factors and associations with mental and behavioral disorders among Australian children and adolescents. PLoS One. 2023, 18:10.1371\/journal.pone.0285940","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12788.1","article-title":"Is panic disorder a disorder of physical fitness? A heuristic proposal","volume":"7","author":"Perna G","year":"2018","unstructured":"Perna G, Caldirola D. Is panic disorder a disorder of physical fitness? A heuristic proposal. F1000Res. 2018, 7:10.12688\/f1000research.12788.1","journal-title":"F1000Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1837","article-title":"Lifetime treatment of DSM-IV mental disorders in the Saudi National Mental Health Survey","volume":"29","author":"Al-Subaie AS","year":"2020","unstructured":"Al-Subaie AS, Altwaijri YA, Al-Habeeb A, et al.. Lifetime treatment of DSM-IV mental disorders in the Saudi National Mental Health Survey. Int J Methods Psychiatr Res. 2020, 29:10.1002\/mpr.1837","journal-title":"Int J Methods Psychiatr Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0590-2","article-title":"Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression","volume":"26","author":"Forstner AJ","year":"2021","unstructured":"Forstner AJ, Awasthi S, Wolf C, et al.. Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression. Mol Psychiatry. 2021, 26:4179-90. 10.1038\/s41380-019-0590-2","journal-title":"Mol Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.25149\/1756-8358.1102013","article-title":"Treating anxiety with either beta blockers or antiemetic antimuscarinic drugs: a review","volume":"11","author":"Dooley TP","year":"2015","unstructured":"Dooley TP. Treating anxiety with either beta blockers or antiemetic antimuscarinic drugs: a review. Ment Health Fam Med. 2015, 11:89-99.","journal-title":"Ment Health Fam Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9479-1","article-title":"Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol\u2122)-application of a new \"physiologically based\" model to assess absorption and disposition","volume":"15","author":"Wang Y","year":"2013","unstructured":"Wang Y, Wang Z, Zuo Z, Tomlinson B, Lee BT, Bolger MB, Chow MS. Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol\u2122)-application of a new \"physiologically based\" model to assess absorption and disposition. AAPS J. 2013, 15:787-96. 10.1208\/s12248-013-9479-1","journal-title":"AAPS J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2174\/1389200222666210614112529","article-title":"A review on pharmacokinetic and pharmacodynamic drug interactions of adrenergic \u03b2-blockers with clinically relevant drugs - an overview","volume":"22","author":"Maideen NM","year":"2021","unstructured":"Maideen NM, Rajkapoor B, Muthusamy S, Ramanathan S, Thangadurai SA, Sughir AA. A review on pharmacokinetic and pharmacodynamic drug interactions of adrenergic \u03b2-blockers with clinically relevant drugs - an overview. Curr Drug Metab. 2021, 22:672-82. 10.2174\/1389200222666210614112529","journal-title":"Curr Drug Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.7.630","article-title":"Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol","volume":"31","author":"Parker RB","year":"2011","unstructured":"Parker RB, Soberman JE. Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol. Pharmacotherapy. 2011, 31:630-41. 10.1592\/phco.31.7.630","journal-title":"Pharmacotherapy"},{"key":"ref13","article-title":"Drug interactions in the treatment of depression in patients receiving \u03b2-blocker drugs","volume":"15","author":"Andrade C","year":"2013","unstructured":"Andrade C. Drug interactions in the treatment of depression in patients receiving \u03b2-blocker drugs. J Clin Psychiatry. 2013, 15:75-8.","journal-title":"J Clin Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/da.10049","article-title":"Reliability of the self-report version of the panic disorder severity scale","volume":"15","author":"Houck PR","year":"2002","unstructured":"Houck PR, Spiegel DA, Shear MK, Rucci P. Reliability of the self-report version of the panic disorder severity scale. Depress Anxiety. 2002, 15:183-5. 10.1002\/da.10049","journal-title":"Depress Anxiety"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-017-0155-1","article-title":"An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample","volume":"16","author":"AlHadi AN","year":"2017","unstructured":"AlHadi AN, AlAteeq DA, Al-Sharif E, et al.. An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample. Ann Gen Psychiatry. 2017, 16:10.1186\/s12991-017-0155-1","journal-title":"Ann Gen Psychiatry"},{"key":"ref16","article-title":"Guidelines for the process of cross-cultural adaptation of self-report measures","volume":"15","author":"Beaton DE","year":"2000","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000, 15:3186-91.","journal-title":"Spine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010676.pub2","article-title":"Antidepressants versus placebo for panic disorder in adults","volume":"4","author":"Bighelli I","year":"2018","unstructured":"Bighelli I, Castellazzi M, Cipriani A, et al.. Antidepressants versus placebo for panic disorder in adults. Cochrane Database Syst Rev. 2018, 4:10.1002\/14651858.CD010676.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2020.12.009","article-title":"The use of \u03b2-adrenergic receptor antagonists in psychiatry: a review","volume":"62","author":"Boyce TG","year":"2021","unstructured":"Boyce TG, Ballone NT, Certa KM, Becker MA. The use of \u03b2-adrenergic receptor antagonists in psychiatry: a review. J Acad Consult Liaison Psychiatry. 2021, 62:404-12. 10.1016\/j.jaclp.2020.12.009","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115612236","article-title":"Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis","volume":"30","author":"Steenen SA","year":"2016","unstructured":"Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A. Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. J Psychopharmacol. 2016, 30:128-39. 10.1177\/0269881115612236","journal-title":"J Psychopharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/EBP.0000000000000167","article-title":"Is pindolol plus an SSRI superior to an SSRI alone in treating patients with panic disorder?","volume":"22","author":"Shea A","year":"2019","unstructured":"Shea A, Feero WG. Is pindolol plus an SSRI superior to an SSRI alone in treating patients with panic disorder?. Evid Based Pract. 2019, 22:32-3. 10.1097\/EBP.0000000000000167","journal-title":"Evid Based Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200010000-00011","article-title":"Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial","volume":"20","author":"Hirschmann S","year":"2000","unstructured":"Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L. Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2000, 20:556-9. 10.1097\/00004714-200010000-00011","journal-title":"J Clin Psychopharmacol"},{"key":"ref22","article-title":"Management of treatment-resistant panic disorder","volume":"4","author":"Holt RL","year":"2007","unstructured":"Holt RL, Lydiard RB. Management of treatment-resistant panic disorder. Psychiatry (Edgmont). 2007, 4:48-59.","journal-title":"Psychiatry (Edgmont)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004164","article-title":"Associations between \u03b2-blockers and psychiatric and behavioural outcomes: a population-based cohort study of 1.4 million individuals in Sweden","volume":"20","author":"Molero Y","year":"2023","unstructured":"Molero Y, Kaddoura S, Kuja-Halkola R, Larsson H, Lichtenstein P, D'Onofrio BM, Fazel S. Associations between \u03b2-blockers and psychiatric and behavioural outcomes: a population-based cohort study of 1.4 million individuals in Sweden. PLoS Med. 2023, 20:10.1371\/journal.pmed.1004164","journal-title":"PLoS Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/286716-comparing-selective-serotonin-reuptake-inhibitors-ssris-alone-and-in-combination-with-beta-blockers-for-treating-panic-disorders-a-prospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T12:37:58Z","timestamp":1725712678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/286716-comparing-selective-serotonin-reuptake-inhibitors-ssris-alone-and-in-combination-with-beta-blockers-for-treating-panic-disorders-a-prospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.68862","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,7]]}}}